Sysmex XN-1000/2000 Technical Guide

Sysmex XN-1000/2000 Technical Guide

In the automation upgrade and daily operation of clinical hematology laboratories, the Sysmex XN series is a highly representative modular analysis platform. As standalone configurations, XN-1000 and XN-2000 correspond to single analysis module and dual analysis module architectures, respectively, providing high sample processing capabilities and clinical scalability within a limited footprint. For laboratory engineers, technical supervisors, and procurement personnel, understanding the module differences, channel principles, parameter systems, sample size requirements, quality control strategies, and common anomaly troubleshooting logic of the XN series can help them make more accurate judgments in equipment installation, method validation, daily maintenance, and troubleshooting.

System positioning and modular architecture

The core analysis modules of the XN series include XN-10 and XN-20. XN-1000 consists of one analysis module, while XN-2000 consists of two analysis modules. Both are independent XN configurations that can achieve a complete hematology testing menu in a small space. The XN-1000 has a maximum throughput of about 100 samples per hour, making it suitable for laboratories with relatively low daily workloads but wide clinical needs. The XN-2000 has a maximum throughput of about 200 samples per hour, making it suitable for laboratories with higher workloads and stricter requirements for continuous operation and result turnover.

An important feature of XN-2000 is automatic workload balancing between dual modules. Two analysis modules can allocate detection tasks based on actual sample loads, reducing the pressure on individual modules and improving overall efficiency. Meanwhile, XN-2000 also supports reagent sharing options, which have practical significance for reagent management, inventory control, and cost optimization. Its "common primary" design concept enables dual modules to complement each other, improve processing capabilities during peak hours, and retain a certain sample processing capability during single module maintenance or exceptions.

The difference between XN-20 module and XN-10 module mainly lies in their advanced channel and parameter capabilities. The WPC channel and HPC parameters are only available on XN-20. WPC is a precursor cell channel for white blood cells, which can be used to indicate abnormal populations of white blood cells such as lymphocytes and primitive cells; HPC is used for counting human progenitor cells and can assist in determining the timing of peripheral blood stem cell collection when additional software activation is required. For laboratories with blood tumors, stem cell transplantation, or special hematological needs, XN-20's scalability is more advantageous.

The XN series supports upgrading from XN-1000 to XN-2000. When the workload of the laboratory increases, an analysis module can be added on the basis of the original configuration without completely replacing the system. The entire XN series adopts universal software, with a consistent operating interface and logic, which can reduce retraining costs. This scalability enables the XN series to not only meet current needs, but also adapt to future clinical project increases and sample size growth.

Laser Flow Core Technology

The XN series uses fluorescence flow cytometry as the core technology for white blood cell classification, reticulocyte, platelet, progenitor cell, and humoral cell analysis. The wavelength of the laser beam is 633 nm. After irradiating the cells passing through the flow chamber, forward scattered light, lateral scattered light, and lateral fluorescence are generated. Forward scattered light reflects cell size information; Lateral scattered light reflects intracellular structural information; Lateral fluorescence reflects the type and quantity of nucleic acids and organelles. By collecting signals of different intensities, the instrument generates scatter maps for each measurement channel for cell classification and abnormal population indication.

The advantage of this technological approach is that different cell populations form relatively independent distribution regions on the scatter map. Taking WDF channel as an example, it can display populations such as lymphocytes, monocytes, eosinophils, neutrophils, basophils, immature granulocytes, and abnormal lymphocytes. The WNR channel is used for counting nucleated red blood cells and white blood cells, supporting direct measurement and correction of NRBC in CBC analysis. The WPC channel further prompts for abnormal lymphocytes, primitive cells, and progenitor cells, providing more information for hematological anomaly screening.

In addition to fluorescence flow cytometry, the XN series also uses hydrodynamic focusing DC detection method for RBC, HCT, and PLT-I impedance detection. Hemoglobin was measured using the cyanide free SLS method. This combination provides a stable technical foundation for the instrument in terms of cell counting, hemoglobin concentration, and platelet counting. For engineers, understanding that different channels correspond to different principles can help quickly identify the source of problems when results are abnormal. For RBC, HCT, PLT-I abnormalities, impedance testing, sheath flow, and sample status can be prioritized for inspection; If there are abnormalities in WBC classification, RET, PLT-F, BF, and HPC, the focus should be on checking the laser flow channel, fluorescent reagent, scatter plot distribution, and sample size.

Standard parameters and channel system

The XN series provides approximately 30 standard parameters, covering the core projects of routine hematological analysis. Standard parameters include WBC、NRBC#、NRBC%、RBC、HGB、HCT、MCV、MCH、MCHC、RDW-SD、RDW-CV、MicroR#、MacroR#、PLT、PDW、MPV、PCT、P-LCR、NEUT#、NEUT%、LYMPH#、LYMPH%、MONO#、MONO%、EO#、EO%、BASO#、BASO%、IG#、IG%。 Among them, the direct measurement and correction of WBC by NRBC are important features of the XN series, which can provide nucleated red blood cell information in each CBC analysis, reducing the need for manual microscopic review.

The WNR channel corresponds to XN-CBC applications, mainly used for white blood cell counting, eosinophils, and nucleated red blood cells. The WDF channel corresponds to the XN-DIFF application, providing 6 categories of white blood cells, including immature granulocytes. The WPC channel corresponds to the WPC application and is used to prompt abnormal white blood cell populations, such as abnormal lymphocytes, primitive cells, etc. For XN-20, HPC parameters can serve as additional value for assisting in determining the timing of peripheral blood stem cell collection. HPC and CD34 analysis have high comparability and can support rapid determination of the optimal collection timing.

In addition to standard parameters, the XN series also offers 16 optional parameters. Optional parameters include RET#、RET%、IRF、LFR、MFR、HFR、RET-He、RBC-He、Delta-He、HYPO-He、HYPER-He、PLT-O、PLT-F、IPF%、IPF#、HPC#/%。 These parameters can be configured and software activated according to the clinical needs of the laboratory. RET related parameters are used for monitoring red blood cell production, and Ret He helps distinguish functional iron deficiency from classical iron deficiency, and can be used for monitoring EPO or intravenous iron therapy. IRF stands for immature reticulocyte fraction, which can reflect the activity of red blood cell generation. PLT-F is a fluorescent platelet counting method that has a good correlation with CD61/41. IPF, which stands for immature platelet fraction, can be used for differential diagnosis of thrombocytopenic diseases and as an early predictor of platelet recovery.

Fluid analysis and special applications

The XN series can be equipped with a body fluid analysis mode, namely BF mode. This mode can perform fully automated analysis on samples such as cerebrospinal fluid, CAPD fluid, synovial fluid, and serum. Fluid analysis provides two categories, including monocyte population and polymorphonuclear cell population, which help distinguish between viral and bacterial infections. BF mode does not require additional reagents or special sample preparation, which can reduce the burden of manual microscopy. The report parameters include WBC-BF, MN #, MN%, PMN #, PMN%, TC-BF #, RBC-BF. For laboratories that need to process body fluid samples, BF mode can significantly improve standardization and turnover efficiency.

The RET channel is another important extension of the XN series. The parameters of reticulocytes include RET #, RET%, IRF, LFR, MFR, HFR, RET He, as well as RBC He, Delta He, HYPER He, etc. These indicators can be used for anemia identification, bone marrow hematopoietic function assessment, treatment monitoring, and transfusion management. Especially as a reticulocyte hemoglobin equivalent, Ret He can reflect iron utilization earlier and has practical value in the management of iron deficiency anemia, chronic disease anemia, and renal anemia.

The PLT-F channel uses fluorescence labeling for platelet counting, which has higher accuracy in low platelet samples. IPF% and IPF # can be used for the differentiation of thrombocytopenia, such as primary immune thrombocytopenia and aplastic thrombocytopenia. For patients undergoing autologous stem cell transplantation or chemotherapy, IPF can predict the recovery of platelet production. HPC parameters are used for peripheral blood stem cell collection management, which can assist in determining the collection timing and improving collection efficiency.

Performance specifications and sample size requirements

The whole blood throughput of XN-1000 and XN-2000 is about 100 samples/hour and 200 samples/hour, respectively. The sample suction volume varies depending on the mode: 88 μ L for whole blood mode, 70 μ L for pre dilution mode, 88 μ L for body fluid mode, and 190 μ L for HPC mode. When developing blood collection vessels, micro collection, and special project procedures in the laboratory, special attention should be paid to the HPC mode requiring a larger sample size to avoid unreliable results or repeated sampling due to insufficient samples.

In terms of quality control, the XN series supports three-level quality control materials for all parameters, as well as two-level body fluid quality control materials. For routine hematology projects, three-level quality control can cover low, medium, and high value ranges, which helps monitor precision and linearity. For fluid analysis, two-level quality control can meet the daily performance verification requirements. Engineers should establish quality control trend charts and regularly check reagent batch numbers, calibration status, laser signals, sheath flow pressure, and scatter plot distribution. If the quality control is out of control, priority should be given to investigating the expiration date of reagents, bottle stability, sample mixing, pipeline bubbles, flow chamber contamination, and software settings.

Selection, Upgrade, and Workflow Optimization

For laboratories with low daily workload and wide clinical demand, XN-1000 is a suitable starting point for entering fully automated hematology analysis. It has onboard decision rules, supports user-defined rerun/flex, and can automatically trigger retesting or add items based on initial inspection results. This rule engine helps reduce manual intervention and improve the efficiency of handling abnormal samples. XN-1000 can also add optional applications according to clinical needs, such as PLT-F, XN-BF, or RET. When the workload increases, XN-1000 can be upgraded to XN-2000, adding a second analysis module to achieve higher throughput and automatic load balancing.

For laboratories with high workload or requiring higher availability, the dual module architecture of XN-2000 has more advantages. Dual modules can process samples simultaneously, reducing turnover time; Automatic load balancing can avoid single module overload; Reagent sharing can reduce the frequency of reagent replacement and human operation differences. The dual module co primary design also means that both modules can jointly undertake routine testing, providing some redundancy in case of maintenance or failure. For laboratories with strong diagnostic and therapeutic needs for blood tumors, transplantation, anemia, and thrombotic diseases, the XN-20 module's capabilities such as WPC, HPC, RET, PLT-F are more clinically valuable.

In method validation and daily operation, attention should be paid to the sample size, channel combination, and reporting parameters of different modes. For example, the sample volume of whole blood mode and pre dilution mode is different, and the sample processing logic of body fluid mode and HPC mode is also different. Laboratories should establish standard operating procedures based on sample types, blood collection vessel specifications, and clinical needs. For projects that require HPC, it is necessary to confirm the software activation status, whether the sample size meets 190 μ L, and whether the quality control covers the corresponding parameters. For BF mode, it should be confirmed whether the sample type, collection container, and reporting parameters meet clinical requirements.

Engineering maintenance and troubleshooting ideas

The troubleshooting of XN series should revolve around five dimensions: "channel principle sample reagent quality control". If the WBC classification is abnormal, first observe whether the WDF, WPC, or WNR scatter plots are clearly clustered. If the scatter plot is blurred, overlapped, or exhibits abnormal tailing, the fluorescence reagent, sheath fluid, laser signal, flow chamber cleanliness, and sample status should be checked. If RBC, PLT-I, HCT are abnormal, impedance detection channels, sheath flow, sample clots, bubbles, and blockages should be checked. If HGB is abnormal, SLS cyanide free hemoglobin reagent, colorimetric cell, and sample hemolysis should be checked.

Scattering map is an important tool for obstacle removal. Abnormal distribution of NRBC, WBC, BASO, and other populations in the WNR channel may indicate an increase in nuclear red blood cells, abnormal white blood cells, or reagent issues. Abnormal populations such as NEUT, LYMPH, MONO, EO, BASO, IG in WDF channels may indicate an increase in immature granulocytes, abnormal lymphocytes, or sample interference. Abnormal lymphocytes, primitive cells, HPC and other areas in the WPC channel should be reviewed in combination with clinical and microscopic examination. Abnormal distribution of RET, IRF, LFR, MFR, and HFR in the RET channel can indicate active erythropoiesis or therapeutic response. Abnormal IPF in the PLT-F channel can indicate the recovery or depletion of platelet production.

Insufficient sample size is a common but easily overlooked issue. Whole blood mode of 88 μ L, pre dilution of 70 μ L, body fluid of 88 μ L, HPC of 190 μ L. If the blood collection volume is insufficient, the sample tube selection is improper, or the mixing is insufficient, it may lead to low results, abnormal classification, or decreased repeatability. For HPC mode, a higher sample volume of 190 μ L is required, and special attention should be paid to the collection vessel capacity and sample quality. For body fluid samples, mucus, cell aggregation, and incompatible collection tubes should be avoided. For pre dilution mode, the dilution ratio and sample processing steps should be confirmed.

The management of reagents and consumables is equally crucial. Fluorescent flow channels are sensitive to reagent quality, bubbles, and contamination. After opening the bottle, the reagent should be stored according to the prescribed conditions to avoid expired use. Bubbles in the pipeline can affect the scattered light signal, leading to abnormal classification. Poor discharge of waste liquid may cause abnormal pressure, affecting sample aspiration and counting. Insufficient or contaminated sheath fluid can lead to poor focusing of the flow chamber and poor clustering of the scatter pattern. Engineers should regularly check the remaining amount of reagents, waste liquid tanks, pipeline connections, flow chamber cleanliness, and air filter status.

Quality control is the core basis for determining the status of instruments. Three level quality control can cover all routine parameters, while two-level body fluid quality control is used in BF mode. If the quality control results drift, calibration, reagent batch number, light source, flow chamber, sampling needle, and software settings should be checked. If multiple parameters are abnormal simultaneously, priority should be given to common components such as sheath flow, laser, pressure, and sample processing. If a single parameter is abnormal, priority should be given to checking the channel and reagent corresponding to that parameter. For advanced parameters such as WPC, HPC, RET, PLT-F, it should be confirmed whether the software activation status and quality control materials are covered.

Reliability and clinical value of results

The technical value of the XN series lies not only in its high throughput, but also in the clinical depth of its parameter system. Standard CBC parameters can meet routine screening, while NRBC direct measurement and correction of WBC can reduce manual review. The six part classification of WDF and IG can provide indications of infection, inflammation, and hematological malignancies. The abnormal population prompt of WPC can help identify primitive cells, abnormal lymphocytes, and HPC. RET and Ret He can be used for anemia differentiation and treatment monitoring. PLT-F and IPF can be used for predicting thrombocytopenia and recovery. The BF mode can enhance the standardization of fluid cell analysis. HPC can assist in determining the timing of stem cell collection.

For laboratory engineers, understanding the clinical background of these parameters can help determine which abnormalities are instrument problems and which are sample or disease-related interferences during troubleshooting. For example, an increase in primitive cells, abnormal lymphocytes, an increase in nucleated red blood cells, platelet aggregation, red blood cell debris, cold agglutination, etc., may all affect scatter plots and counting results. If there is an abnormal group in the scatter plot, it should be comprehensively judged based on alarm information, microscopic examination review, and clinical information, rather than simply attributed to instrument failure.